Drug Repurposing News and Research

RSS
Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2

Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Transcriptomics identifies possible COVID-19 therapies

Transcriptomics identifies possible COVID-19 therapies

CRISPR screening identifies human host pathways that facilitate coronavirus infection

CRISPR screening identifies human host pathways that facilitate coronavirus infection

Study shows effectiveness of UV-C light for killing COVID-19 on N95 respirators

Study shows effectiveness of UV-C light for killing COVID-19 on N95 respirators

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

Can amodiaquine short circuit this pandemic?

Can amodiaquine short circuit this pandemic?

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

Cat antiviral that inhibits SARS-CoV-2 fast-tracked for human clinical trials

Cat antiviral that inhibits SARS-CoV-2 fast-tracked for human clinical trials

Scientists describe known approaches for treatment of SARS-CoV-2 infection

Scientists describe known approaches for treatment of SARS-CoV-2 infection

Bioinsider presents ‘Therapeutic Pipeline for COVID-19’ virtual meeting on September 17, 2020

Bioinsider presents ‘Therapeutic Pipeline for COVID-19’ virtual meeting on September 17, 2020

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

CARE consortium launches to accelerate drug discovery and development for COVID-19

CARE consortium launches to accelerate drug discovery and development for COVID-19

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Artificial intelligence can increase effectiveness of drug repurposing for psychiatric disorders

Artificial intelligence can increase effectiveness of drug repurposing for psychiatric disorders

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors